The insurer (also known as Elevance) first launched its new “nonparticipating care providers” policy across 11 states beginning on Jan. 1, drawing widespread criticism.
The risk associated with under-recognized CKD emerged early, highlighting the need for screening soon after a CAD diagnosis so that cardio-renal protective drugs can be started much earlier.
The organization has grown significantly in recent years, and like similar imaging groups, faced mounting challenges in automating core front-office functions, verifying insurance benefits and helping staff struggling to keeping up with it all.
